Awad, Amani
Registration #210760
Page 4 of 61
amended, and subsection 2(1)17 of Ontario Regulation 130/17, as amended, and/or
subsection 1(15) of Ontario Regulation 681/93, as amended, in that, while engaged
in the practice of pharmacy as director, shareholder, owner, designated manager,
and/or dispensing pharmacist at the Pharmacy in Etobicoke, Ontario, she signed or
issued, in her professional capacity, a document that she knew and/or ought to have
known contained a false or misleading statement with respect to one or more of the
drugs and/or products listed in Appendix “A” and Appendix “B” from in or about
January 2015 to in or about September 2017.
5.
She committed an act or acts of professional misconduct as provided by subsection
51(1)(c) of the Health Professions Procedural Code of the Pharmacy Act, 1991, as
amended, and subsection 2(1)20 of Ontario Regulation 130/17, as amended, and/or
subsection 1(16) of Ontario Regulation 681/93, as amended, in that, while engaged
in the practice of pharmacy as director, shareholder, owner, designated manager,
and/or dispensing pharmacist at the Pharmacy in Etobicoke, Ontario, she submitted
an account or charge for services or products that she knew and/or ought to have
known was false or misleading for one or more of the drugs and/or products listed
in Appendix “A” and Appendix “B” from in or about January 2015 to in or about
September 2017.
6.
She committed an act or acts of professional misconduct as provided by subsection
51(1)(c) of the Health Professions Procedural Code of the Pharmacy Act, 1991, as
amended, and subsection 2(1)23 of Ontario Regulation 130/17, as amended, and/or
subsection 1(21) of Ontario Regulation 681/93, as amended, in that, while engaged
in the practice of pharmacy as director, shareholder, owner, designated manager,
and/or dispensing pharmacist at the Pharmacy in Etobicoke, Ontario, she
contravened the Pharmacy Act, 1991, the Drug and Pharmacies Regulation Act,
the Regulated Health Professions Act, 1991, the Narcotics Safety and Awareness
Act, 2010, the Drug Interchangeability and Dispensing Fee Act or the Ontario
Drug Benefit Act or the regulations under those Acts, and in particular:
a. sections 155(1), 156, 163, and 166 of the Drug and Pharmacies Regulation Act,
section 20(1) of Ontario Regulation 264/16, and sections 40(1) and 54(1) of
Ontario Regulation 58/11 with respect to:
i.
dispensing and/or billing for drugs and/or products without a
prescription authorized by a prescriber for one or more of the drugs
and/or products listed in Appendix “A” and Appendix “B” from in or
about January 2015 to in or about September 2017; and/or
ii.
failing to keep records as required for one or more of the drugs and/or
products listed in Appendix “A” and Appendix “B” from in or about
January 2015 to in or about September 2017.
7.
She committed an act or acts of professional misconduct as provided by subsection
51(1)(c) of the Health Professions Procedural Code of the Pharmacy Act, 1991, as